Business Description
PolyPeptide Group AG
ISIN : CH1110760852
Compare
Compare
Traded in other countries / regions
PPGN.SwitzerlandPPGNz.UK IPO Date
2021-04-29Description
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.84 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | -4.98 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.82 | |||||
| Beneish M-Score | 3.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.5 | |||||
| 3-Year Book Growth Rate | 23.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | 11.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.56 | |||||
| 9-Day RSI | 59.24 | |||||
| 14-Day RSI | 62.51 | |||||
| 6-1 Month Momentum % | 79.9 | |||||
| 12-1 Month Momentum % | 40.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.85 | |||||
| Quick Ratio | 1.12 | |||||
| Cash Ratio | 0.54 | |||||
| Days Inventory | 165.09 | |||||
| Days Sales Outstanding | 72.92 | |||||
| Days Payable | 52.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | -7.29 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 1.3 | |||||
| Operating Margin % | -11.59 | |||||
| Net Margin % | -16.2 | |||||
| FCF Margin % | -7.08 | |||||
| ROE % | -12.94 | |||||
| ROA % | -8.3 | |||||
| ROIC % | -6.22 | |||||
| ROC (Joel Greenblatt) % | -12.17 | |||||
| ROCE % | -10.98 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.18 | |||||
| PB Ratio | 2.71 | |||||
| Price-to-Tangible-Book | 2.83 | |||||
| Price-to-Operating-Cash-Flow | 29.76 | |||||
| EV-to-EBIT | -19.55 | |||||
| EV-to-Forward-EBIT | 132.46 | |||||
| EV-to-EBITDA | -46.09 | |||||
| EV-to-Forward-EBITDA | 15.09 | |||||
| EV-to-Revenue | 3.24 | |||||
| EV-to-Forward-Revenue | 1.84 | |||||
| EV-to-FCF | -45.75 | |||||
| Price-to-Net-Current-Asset-Value | 54.72 | |||||
| Earnings Yield (Greenblatt) % | -5.12 | |||||
| FCF Yield % | -2.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PolyPeptide Group AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 306.412 | ||
| EPS (TTM) (CHF) | -1.505 | ||
| Beta | 2.37 | ||
| Volatility % | 103.69 | ||
| 14-Day RSI | 62.51 | ||
| 14-Day ATR (CHF) | 1.18794 | ||
| 20-Day SMA (CHF) | 29.0825 | ||
| 12-1 Month Momentum % | 40.5 | ||
| 52-Week Range (CHF) | 14.11 - 31.14 | ||
| Shares Outstanding (Mil) | 32.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PolyPeptide Group AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PolyPeptide Group AG Stock Events
| Event | Date | Price(CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
PolyPeptide Group AG Frequently Asked Questions
What is PolyPeptide Group AG(XSWX:PPGN)'s stock price today?
The current price of XSWX:PPGN is CHF29.55. The 52 week high of XSWX:PPGN is CHF31.14 and 52 week low is CHF14.11.
When is next earnings date of PolyPeptide Group AG(XSWX:PPGN)?
The next earnings date of PolyPeptide Group AG(XSWX:PPGN) is .
Does PolyPeptide Group AG(XSWX:PPGN) pay dividends? If so, how much?
PolyPeptide Group AG(XSWX:PPGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers